Cargando…

Interventions for Infection and Inflammation-Induced Preterm Birth: a Preclinical Systematic Review

Spontaneous preterm births (< 37 weeks gestation) are frequently associated with infection. Current treatment options are limited but new therapeutic interventions are being developed in animal models. In this PROSPERO-registered preclinical systematic review, we aimed to summarise promising inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Faith A., Sacco, Adalina, David, Anna L., Boyle, Ashley K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988807/
https://www.ncbi.nlm.nih.gov/pubmed/35426035
http://dx.doi.org/10.1007/s43032-022-00934-x
_version_ 1784901645876854784
author Miller, Faith A.
Sacco, Adalina
David, Anna L.
Boyle, Ashley K.
author_facet Miller, Faith A.
Sacco, Adalina
David, Anna L.
Boyle, Ashley K.
author_sort Miller, Faith A.
collection PubMed
description Spontaneous preterm births (< 37 weeks gestation) are frequently associated with infection. Current treatment options are limited but new therapeutic interventions are being developed in animal models. In this PROSPERO-registered preclinical systematic review, we aimed to summarise promising interventions for infection/inflammation-induced preterm birth. Following PRISMA guidance, we searched PubMed, EMBASE, and Web of Science using the themes: “animal models”, “preterm birth”, “inflammation”, and “therapeutics”. We included original quantitative, peer-reviewed, and controlled studies applying prenatal interventions to prevent infection/inflammation-induced preterm birth in animal models. We employed two risk of bias tools. Of 4020 identified studies, 23 studies (24 interventions) met our inclusion criteria. All studies used mouse models. Preterm birth was most commonly induced by lipopolysaccharide (18 studies) or Escherichia coli (4 studies). Models varied according to infectious agent serotype, dose, and route of delivery. Gestational length was significantly prolonged in 20/24 interventions (83%) and markers of maternal inflammation were reduced in 20/23 interventions (87%). Interventions targeting interleukin-1, interleukin-6, and toll-like receptors show particular therapeutic potential. However, due to the heterogeneity of the methodology of the included studies, meta-analysis was impossible. All studies were assigned an unclear risk of bias using the SYRCLE risk of bias tool. Interventions targeting inflammation demonstrate therapeutic potential for the prevention of preterm birth. However, better standardisation of preterm birth models, including the dose, serotype, timing of administration and pathogenicity of infectious agent, and outcome reporting is urgently required to improve the reproducibility of preclinical studies, allow meaningful comparison of intervention efficacy, and aid clinical translation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s43032-022-00934-x.
format Online
Article
Text
id pubmed-9988807
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-99888072023-03-08 Interventions for Infection and Inflammation-Induced Preterm Birth: a Preclinical Systematic Review Miller, Faith A. Sacco, Adalina David, Anna L. Boyle, Ashley K. Reprod Sci Review Spontaneous preterm births (< 37 weeks gestation) are frequently associated with infection. Current treatment options are limited but new therapeutic interventions are being developed in animal models. In this PROSPERO-registered preclinical systematic review, we aimed to summarise promising interventions for infection/inflammation-induced preterm birth. Following PRISMA guidance, we searched PubMed, EMBASE, and Web of Science using the themes: “animal models”, “preterm birth”, “inflammation”, and “therapeutics”. We included original quantitative, peer-reviewed, and controlled studies applying prenatal interventions to prevent infection/inflammation-induced preterm birth in animal models. We employed two risk of bias tools. Of 4020 identified studies, 23 studies (24 interventions) met our inclusion criteria. All studies used mouse models. Preterm birth was most commonly induced by lipopolysaccharide (18 studies) or Escherichia coli (4 studies). Models varied according to infectious agent serotype, dose, and route of delivery. Gestational length was significantly prolonged in 20/24 interventions (83%) and markers of maternal inflammation were reduced in 20/23 interventions (87%). Interventions targeting interleukin-1, interleukin-6, and toll-like receptors show particular therapeutic potential. However, due to the heterogeneity of the methodology of the included studies, meta-analysis was impossible. All studies were assigned an unclear risk of bias using the SYRCLE risk of bias tool. Interventions targeting inflammation demonstrate therapeutic potential for the prevention of preterm birth. However, better standardisation of preterm birth models, including the dose, serotype, timing of administration and pathogenicity of infectious agent, and outcome reporting is urgently required to improve the reproducibility of preclinical studies, allow meaningful comparison of intervention efficacy, and aid clinical translation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s43032-022-00934-x. Springer International Publishing 2022-04-14 /pmc/articles/PMC9988807/ /pubmed/35426035 http://dx.doi.org/10.1007/s43032-022-00934-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review
Miller, Faith A.
Sacco, Adalina
David, Anna L.
Boyle, Ashley K.
Interventions for Infection and Inflammation-Induced Preterm Birth: a Preclinical Systematic Review
title Interventions for Infection and Inflammation-Induced Preterm Birth: a Preclinical Systematic Review
title_full Interventions for Infection and Inflammation-Induced Preterm Birth: a Preclinical Systematic Review
title_fullStr Interventions for Infection and Inflammation-Induced Preterm Birth: a Preclinical Systematic Review
title_full_unstemmed Interventions for Infection and Inflammation-Induced Preterm Birth: a Preclinical Systematic Review
title_short Interventions for Infection and Inflammation-Induced Preterm Birth: a Preclinical Systematic Review
title_sort interventions for infection and inflammation-induced preterm birth: a preclinical systematic review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988807/
https://www.ncbi.nlm.nih.gov/pubmed/35426035
http://dx.doi.org/10.1007/s43032-022-00934-x
work_keys_str_mv AT millerfaitha interventionsforinfectionandinflammationinducedpretermbirthapreclinicalsystematicreview
AT saccoadalina interventionsforinfectionandinflammationinducedpretermbirthapreclinicalsystematicreview
AT davidannal interventionsforinfectionandinflammationinducedpretermbirthapreclinicalsystematicreview
AT boyleashleyk interventionsforinfectionandinflammationinducedpretermbirthapreclinicalsystematicreview